男性乳房发育

Nuttall FQ. Gynecomastia as a physical finding in normal men. J Clin Endocrinol Metab. 1979 Feb;48(2):338-40. 摘要

Carlson HE. Approach to the patient with gynecomastia. J Clin Endocrinol Metab. 2011 Jan;96(1):15-21.全文  摘要

Bhasin S, Brito JP, Cunningham GR, et al. Testosterone therapy in men with hypogonadism: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab. 2018 May 1;103(5):1715-44.全文  摘要

American College of Radiology. ACR Appropriateness Criteria. Evaluation of the symptomatic male breast. 2018 [internet publication].全文

Kanakis GA, Nordkap L, Bang AK, et al. EAA clinical practice guidelines-gynecomastia evaluation and management. Andrology. 2019 Nov;7(6):778-93.全文  摘要

Soliman AT, De Sanctis V, Yassin M. Management of adolescent gynecomastia: an update. Acta Biomed. 2017 Aug 23;88(2):204-213.全文  摘要

1. Niewoehner CB, Schorer AE. Gynaecomastia and breast cancer in men. BMJ. 2008 Mar 29;336(7646):709-13. 摘要

2. Simon BE, Hoffman S, Kahn S. Classification and surgical correction of gynecomastia. Plast Reconstr Surg. 1973 Jan;51(1):48-52. 摘要

3. McKiernan JF, Hull D. Breast development in the newborn. Arch Dis Child. 1981 Jul;56(7):525-9.全文  摘要

4. Nydick M, Bustos J, Dale JH Jr, et al. Gynecomastia in adolescent boys. JAMA. 1961 Nov 4;178:449-54. 摘要

5. Nuttall FQ. Gynecomastia as a physical finding in normal men. J Clin Endocrinol Metab. 1979 Feb;48(2):338-40. 摘要

6. Niewoehner CB, Nuttall FQ. Gynecomastia in a hospitalized male population. Am J Med. 1984 Oct;77(4):633-8. 摘要

7. Anderson JA, Gram JB. Male breast at autopsy. Acta Pathol Microbiol Immunol Scand. 1982 May;90(3):191-7. 摘要

8. Travison TG, Araujo AB, Kupelian V, et al. The relative contributions of aging, health and lifestyle factors to serum testosterone decline in men. J Clin Endocrinol Metab. 2007 Feb;92(2):549-55.全文  摘要

9. Harman SM, Metter EJ, Tobin JD, et al. Longitudinal effects of aging on serum total and free testosterone levels in healthy men. J Clin Endocrinol Metab. 2001 Feb;86(2):724-31.全文  摘要

10. Braunstein GD. Gynecomastia. New Engl J Med. 1993 Feb 18;328(7):490-95. 摘要

11. Carlson HE. Approach to the patient with gynecomastia. J Clin Endocrinol Metab. 2011 Jan;96(1):15-21.全文  摘要

12. Deepinder F, Braunstein GD. Drug-induced gynecomastia: an evidence-based review. Expert Opin Drug Saf. 2012 Sep;11(5):779-95. 摘要

13. Nuttall FQ, Warrier RS, Gannon MC. Gynecomastia and drugs: a critical evaluation of the literature. Eur J Clin Pharmacol. 2015 May;71(5):569-78.全文  摘要

14. Shozu M, Sebastian S, Takayama K, et al. Estrogen excess associated with novel gain-of-function mutations affecting the aromatase gene. N Engl J Med. 2003 May 8;348(19):1855-65. 摘要

15. Dobs A, Darkes MJ. Incidence and management of gynecomastia in men treated for prostate cancer. J Urol. 2005 Nov;174(5):1737-42. 摘要

16. Schulman C, Pommerville P, Hofner K, et al. Long-term therapy with the dual 5alpha-reductase inhibitor dusteride is well tolerated in men with symptomatic benign prostatic hyperplasia. BJU Int. 2006 Jan;97(1):73-9. 摘要

17. Jensen RT, Collen MJ, Pandol SJ, et al. Cimetidine-induced impotence and breast changes in patients with gastric hypersecretory states. N Engl J Med. 1983 Apr 14;308(15):883-7. 摘要

18. Thompson DF, Carter JR. Drug-induced gynecomastia. Pharmacotherapy. 1993 Jan-Feb;13(1):37-45. 摘要

19. Finkelstein JS, McCully WF, MacLaughlin DT, et al. The mortician's mystery: gynecomastia and reversible hypogonadotropic hypogonadism in an embalmer. N Engl J Med. 1988 Apr 14;318(15):961-5. 摘要

20. Harrington JM, Stein GF, Rivera RO, et al. The occupational hazards of formulating oral contraceptives: a survey of plant employees. Arch Environ Health. 1978 Jan-Feb;33(1):12-5. 摘要

21. Henley DV, Lipson N, Korach KS, et al. Prepubertal gynecomastia linked to lavender and tea tree oils. N Engl J Med. 2007 Feb 1;356(5):479-85.全文  摘要

22. Durmaz E, Özmert EN, Erkekoğlu P, et al. Plasma phthalate levels in pubertal gynecomastia. Pediatrics. 2010 Jan;125(1):e122-9.全文  摘要

23. Huffman DH, Kampmann JP, Hignite CE, et al. Gynecomastia induced in normal males by spironolactone. Clin Pharmacol Ther. 1978 Oct;24(4):465-73. 摘要

24. Bagatell CJ, Bremner WJ. Androgens in men: uses and abuses. N Engl J Med. 1996 Mar 14;334(11):707-14. 摘要

25. Perry PJ, Lund BC, Deninger MJ, et al. Anabolic steroid use in weight lifters and body builders: an internet survey of drug utilization. Clin J Sport Med. 2005 Sep;15(5):326-30. 摘要

26. Friedl KE, Yesalis CE. Self-treatment of gynecomastia in bodybuilders who use anabolic steroids. Physician Sportsmed. 1989 Mar;17(3):67-79. 摘要

27. Mira JA, Lozano F, Santos J, et al. Gynaecomastia in HIV-infected men on highly active antiretroviral therapy: association with efavirenz and didanosine treatment. Antivir Ther. 2004 Aug;9(4):511-17. 摘要

28. Dobs AS, Meikle AW, Arver S, et al. Pharmacokinetics, efficacy, and safety of a permeation-enhanced testosterone transdermal system in comparison with bi-weekly injections of testosterone enanthate for the treatment of hypogonadal men. J Clin Endocrinol Metab. 1999 Oct;84(10):3469-78.全文  摘要

29. Boccardo F, Rubagotti A, Battaglia M, et al. Evaluation of tamoxifen and anastrozole in the prevention of gynecomastia and breast pain induced by bicalutamide monotherapy of prostate cancer. J Clin Oncol. 2005 Feb 1;23(4):808-15.全文  摘要

30. Salzstein D, Sieber P, Morris T, et al. Prevention and management of bicalutamide-induced gynecomastia and breast pain: randomized endocrinologic and clinical studies with tamoxifen and anastrozole. Prostate Cancer Prostatic Dis. 2005;8(1):75-83.全文  摘要

31. Fradet Y, Egerdie B, Andersen M, et al. Tamoxifen as prophylaxis for prevention of gynaecomastia and breast pain associated with bicalutamide 150 mg monotherapy in patients with prostate cancer: a randomised, placebo-controlled, dose-response study. Eur Urol. 2007 Jul;52(1):106-14. 摘要

32. Viani GA, Bernardes da Silva LG, Stefano EJ. Prevention of gynecomastia and breast pain caused by androgen deprivation therapy in prostate cancer: tamoxifen or radiotherapy? Int J Radiat Oncol Biol Phys. 2012 Jul 15;83(4):e519-24. 摘要

33. Kunath F, Keck B, Antes G, et al. Tamoxifen for the management of breast events induced by non-steroidal antiandrogens in patients with prostate cancer: a systematic review. BMC Med. 2012 Aug 28;10:96.全文  摘要

34. Lawrence SE, Faught KA, Vethamuthu J, et al. Beneficial effects of raloxifene and tamoxifen in the treatment of pubertal gynecomastia. J Pediatr. 2004 Jul;145(1):71-6. 摘要

35. Tyrrell CJ, Payne H, Tammela TL, et al. Prophylactic breast irradiation with a single dose of electron beam radiotherapy (10 Gy) significantly reduces the incidence of bicalutamide-induced gynecomastia. Int J Rad Oncol Biol Phys. 2004 Oct 1;60(2):476-83. 摘要

36. Perdonà S, Autorino R, De Placido S, et al. Efficacy of tamoxifen and radiotherapy for prevention and treatment of gynecomastia and breast pain caused by bicalutamide in prostate cancer: a randomised controlled trial. Lancet Oncol. 2005 May;6(5):295-300. 摘要

37. Bhasin S, Brito JP, Cunningham GR, et al. Testosterone therapy in men with hypogonadism: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab. 2018 May 1;103(5):1715-44.全文  摘要

38. American College of Radiology. ACR Appropriateness Criteria. Evaluation of the symptomatic male breast. 2018 [internet publication].全文

39. Kanakis GA, Nordkap L, Bang AK, et al. EAA clinical practice guidelines-gynecomastia evaluation and management. Andrology. 2019 Nov;7(6):778-93.全文  摘要

40. Narula HS, Carlson HE. Gynaecomastia-pathophysiology, diagnosis and treatment. Nat Rev Endocrinol. 2014 Nov;10(11):684-98. 摘要

41. Janes SE, Lengyel JA, Singh S, et al. Needle core biopsy for the assessment of unilateral breast masses in men. Breast. 2006 Apr;15(2):273-5. 摘要

42. Hines SL, Tan WW, Yasrebi M, et al. The role of mammography in male patients with breast symptoms. Mayo Clin Proc. 2007 Mar;82(3):297-300. 摘要

43. Gao Y, Goldberg JE, Young TK, et al. Breast cancer screening in high-risk men: a 12-year longitudinal observational study of male breast imaging utilization and outcomes. Radiology. 2019 Nov;293(2):282-91.全文  摘要

44. McDermott MT, Hofeldt FD, Kidd GS. Tamoxifen therapy for painful, idiopathic gynecomastia. South Med J. 1990 Nov;83(11):1283-5. 摘要

45. Hanavadi S, Banerjee D, Monypenny IJ, et al. The role of tamoxifen in the management of gynaecomastia. Breast. 2006 Apr;15(2):276-80. 摘要

46. Mannu GS, Sudul M, Bettencourt-Silva JH, et al. Role of tamoxifen in idiopathic gynecomastia: A 10-year prospective cohort study. Breast J. 2018 Nov;24(6):1043-5. 摘要

47. Ting AC, Chow LW, Leung YF. Comparison of tamoxifen with danazol in the management of idiopathic gynecomastia. Am Surg. 2000 Jan;66(1):38-40. 摘要

48. Buckle R. Danazol therapy in gynaecomastia; recent experience and indications for therapy. Postgrad Med J. 1979;55 Suppl 5:71-8. 摘要

49. Babigian A, Silverman RT. Management of gynecomastia due to use of anabolic steroids in bodybuilders. Plast Reconstr Surg. 2001 Jan;107(1):240-42. 摘要

50. Fruhstorfer BH, Malata CM. A systematic approach to the surgical treatment of gynaecomastia. Br J Plast Surg. 2003 Apr;56(3):237-46. 摘要

51. Persichetti P, Berloco M, Casadei RM, et al. Gynecomastia and the complete circumareolar approach in the surgical management of skin redundancy. Plast Reconstr Surg. 2001 Apr 1;107(4):948-54. 摘要

52. Hodgson EL, Fruhstorfer BH, Malata CM. Ultrasonic liposuction in the treatment of gynecomastia. Plast Reconstr Surg. 2005 Aug;116(2):646-53. 摘要

53. Gabra HO, Morabito A, Bianchi A, et al. Gynaecomastia in the adolescent: a surgically relevant condition. Eur J Pediatr Surg. 2004 Feb;14(1):3-6. 摘要

54. Colombo-Benkmann M, Buse B, Stern J, et al. Indications for and results of surgical therapy for male gynecomastia. Am J Surg. 1999 Jul;178(1):60-3. 摘要

55. Trelles MA, Mordon SR, Bonanad E, et al. Laser-assisted lipolysis in the treatment of gynecomastia: a prospective study in 28 patients. Lasers Med Sci. 2013 Feb;28(2):375-82. 摘要

56. Bedognetti D, Rubagotti A, Conti G, et al. An open, randomised, multicentre, phase 3 trial comparing the efficacy of two tamoxifen schedules in preventing gynaecomastia induced by bicalutamide monotherapy in prostate cancer patients. Eur Urol. 2010 Feb;57(2):238-45. 摘要

57. Serretta V, Altieri V, Morgia G, et al. A randomized trial comparing tamoxifen therapy vs. tamoxifen prophylaxis in bicalutamide-induced gynecomastia. Clin Genitourin Cancer. 2012 Sep;10(3):174-9. 摘要

58. Van Poppel H, Tyrrell CJ, Haustermans K, et al. Efficacy and tolerability of radiotherapy as treatment for bicalutamide-induced gynaecomastia and breast pain in prostate cancer. Eur Urol. 2005 May;47(5):587-92. 摘要

59. Ozen H, Akyol F, Toktas G, et al. Is prophylactic breast radiotherapy necessary in all patients with prostate cancer and gynecomastia and/or breast pain? J Urol. 2010 Aug;184(2):519-24. 摘要

60. Tunio MA, Al-Asiri M, Al-Amro A, et al. Optimal prophylactic and definitive therapy for bicalutamide-induced gynecomastia: results of a meta-analysis. Curr Oncol. 2012 Aug;19(4):e280-8.全文  摘要

61. Soliman AT, De Sanctis V, Yassin M. Management of adolescent gynecomastia: an update. Acta Biomed. 2017 Aug 23;88(2):204-213.全文  摘要

62. Mieritz MG, Rakêt LL, Hagen CP, et al. A longitudinal study of growth, sex steroids, and IGF-1 in boys with physiological gynecomastia. J Clin Endocrinol Metab. 2015 Oct;100(10):3752-9.全文  摘要

63. Nuzzi LC, Cerrato FE, Erickson CR, et al. Psychosocial impact of adolescent gynecomastia: a prospective case-control study. Plast Reconstr Surg. 2013 Apr;131(4):890-96. 摘要

64. Lapid O, van Wingerden JJ, Perlemuter L. Tamoxifen therapy for the management of pubertal gynecomastia: a systematic review. J Pediatr Endocrinol Metab. 2013;26(9-10):803-7. 摘要

65. Eberle AJ, Sparrow JT, Keenan BS. Treatment of persistent pubertal gynecomastia with dihydrotestosterone heptanoate. J Pediatr. 1986 Jul;109(1):144-9. 摘要

66. Plourde PV, Kulin HE, Santner SJ. Clomiphene in the treatment of adolescent gynecomastia. Am J Dis Child. 1983 Nov;137(11):1080-2. 摘要

67. Koshy JC, Goldberg JS, Wolfswinkel EM, et al. Breast cancer incidence in adolescent males undergoing subcutaneous mastectomy for gynecomastia: is pathologic examination justified? A retrospective and literature review. Plast Reconstr Surg. 2011 Jan;127(1):1-7. 摘要

68. Einav-Bachar R, Phillip M, Aurbach-Klipper Y, et al. Prepubertal gynaecomastia: aetiology, course and outcome. Clin Endocrinol. 2004 Jul;61(1):55-60. 摘要

69. Benveniste O, Simon A, Herson S. Successful percutaneous dihydrotestosterone treatment of gynecomastia occurring during highly active retroviral therapy: four cases and a review of the literature. Clin Infect Dis. 2001 Sep 15;33(6):891-3.全文  摘要